Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
ZAFIRLUKAST
PCO Manufacturing
R03DC01
ZAFIRLUKAST
20 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Leukotriene receptor antagonists
Authorised
2007-06-08
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER ACCOLATE ® 20MG FILM-COATED TABLETS zafirlukast READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Accolate is and what it is used for 2. Before you take Accolate 3. How to take Accolate 4. Possible side effects 5. How to store Accolate 6. Further information 1. WHAT ACCOLATE IS AND WHAT IT IS USED FOR Accolate contains a medicine called zafirlukast. This belongs to a group of medicines called ‘leukotriene antagonists’. This means that it reduces the effects of ‘leukotrienes’. These are natural substances in the lung that cause asthma. Accolate is used to control the symptoms of your asthma. It is also used to prevent your asthma from getting worse. Do not take Accolate to treat sudden (acute) asthma attacks. Your doctor will provide you with other inhalers to treat sudden attacks. 2. BEFORE YOU TAKE ACCOLATE DO NOT TAKE ACCOLATE IF: You are allergic (hypersensitive) to zafirlukast or any of the other ingredients of Accolate (listed in Section 6: Further information). You have a chronic liver condition. Do not take Accolate if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Accolate. TAKE SPECIAL CARE WITH ACCOLATE Check with your doctor or pharmacist before taking Accolate if: You have had problems with your li Leggi il documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Accolate 20mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Accolate contains 20mg of zafirlukast in each tablet. Excipients: Lactose. For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablet _Product imported from the UK:_ White, round, biconvex film-coated tablets intagliated with ‘Accolate 20’ on one side and plain on the reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Accolate is indicated for the prophylaxis and chronic treatment of asthma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Accolate is taken to prevent asthma attacks and should therefore be taken continuously. ADULTS AND CHILDREN AGED 12 YEARS AND OVER: Therapy should be initiated at 20mg twice daily. The usual maintenance dosage is 20mg twice daily. Increasing the dose, titrating to a maximum of 40mg twice daily, may provide additional benefit. This dose should not be exceeded because higher doses may be associated with hepatotoxicity. AS FOOD MAY REDUCE THE BIOAVAILABILITY OF ZAFIRLUKAST, ACCOLATE SHOULD NOT BE TAKEN WITH MEALS. ELDERLY The clearance of zafirlukast is reduced in elderly patients >65 years old), such that Cmax and AUC are approximately twice those of younger adults. However, accumulation of Accolate is not evident in elderly patients. In clinical trials, elderly patients receiving a dose of 20mg twice daily were not associated with an increase in the overall incidence of adverse events or withdrawals because of adverse events. Therapy may be initiated at 20mg twice daily and adjusted according to clinical response. CHILDREN: The safety and efficacy of Accolate in children under 12 years has not been established. Until further information on use in children is av Leggi il documento completo